The global computer-aided drug discovery market size was US$ 2,845 million in 2021. The global computer-aided drug discovery market size is forecast to reach US$ 7,232 million by 2030, growing at a compound annual growth rate (CAGR) of 11.3% during the forecast period from 2022 to 2030.
A cutting-edge computational technique used in drug development to find and utilize prospective leads is called computer-aided drug discovery (CADD). Aspects of computer-aided drug design include computational chemistry, molecular modeling, molecular design, and rational drug design. The quality of leads that have been identified is being improved using CADD. CADD techniques are becoming more well-liked and well-accepted in academic and pharmaceutical circles. In the global drug development process, CADD is a useful technique for locating possible medicinal molecules. Since CADD techniques and technologies have the ability to speed up the hit identification, strike to lead, and result enhancement processes, they have been used in nearly every stage of the drug development pipeline.
Factors Influencing Market Growth
Impact Analysis of COVID-19
The COVID-19 pandemic had a positive impact on the global market. Due to increasing R&D efforts by scientists, researchers, and biotech & biopharmaceutical businesses in order to stop the COVID-19 from spreading. The global search for a cure or medicine to combat this deadly illness has been sparked by the coronavirus's rising rate of transmutation. As a result, the significance of research and drug discovery has increased dramatically, fueling the market's expansion.
Regional Analysis
North America garnered a significant market share in 2021 and is forecast to have substantial growth during the forecast period. As a result of the growing number of cancer patients. Additionally, growing research activities at institutes and hospitals have also installed and elevated their cancer investigation procedures using computer-aided drug discovery.
Leading Competitors
The leading prominent companies profiled in the global computer-aided drug discovery market are:
Scope of the Report
The global computer-aided drug discovery market segmentation focuses on Type, Therapeutic Area, End-User, and Region.
Segmentation based on Type
Segmentation based on Therapeutic Area
Segmentation based on End-User
Segmentation based on Region
[TABLE OF CONTENTS]
1 INTRODUCTION OF GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
4 GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE MODEL
4.4 VALUE CHAIN ANALYSIS
5 GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET, BY TYPE
5.1 OVERVIEW
5.2 STRUCTURE-BASED DRUG DESIGN
5.3 SEQUENCE-BASED APPROACHES
5.4 LIGAND-BASED DRUG DESIGN
6 GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA
6.1 OVERVIEW
6.2 ONCOLOGY
6.3 DIABETES
6.4 CARDIOVASCULAR DISEASES
6.5 NEUROLOGY
6.6 RESPIRATORY DISEASES
6.7 OTHERS
7 GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET, BY END-USER
7.1 OVERVIEW
7.2 PHARMACEUTICAL COMPANIES
7.3 RESEARCH LABORATORIES
7.4 BIOTECHNOLOGY COMPANIES
8 GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET, BY GEOGRAPHY
8.1 OVERVIEW
8.2 NORTH AMERICA
8.2.1 NORTH AMERICA MARKET SNAPSHOT
8.2.2 U.S.
8.2.3 CANADA
8.2.4 MEXICO
8.3 EUROPE
8.3.1 EUROPE MARKET SNAPSHOT
8.3.2 WESTERN EUROPE
8.3.2.1 THE UK
8.3.2.2 GERMANY
8.3.2.3 FRANCE
8.3.2.4 ITALY
8.3.2.5 SPAIN
8.3.2.6 REST OF WESTERN EUROPE
8.3.3 EASTERN EUROPE
8.3.3. 1 POLAND
8.3.3.2 RUSSIA
8.3.3.3 REST OF EASTERN EUROPE
8.4 ASIA PACIFIC
8.4.1 ASIA PACIFIC MARKET SNAPSHOT
8.4.2 CHINA
8.4.3 JAPAN
8.4.4 INDIA
8.4.5 AUSTRALIA & NEW ZEALAND
8.4.6 ASEAN
8.4.7 REST OF ASIA PACIFIC
8.5 MIDDLE EAST & AFRICA
8.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
8.5.2 UAE
8.5.3 SAUDI ARABIA
8.5.4 SOUTH AFRICA
8.5.5 REST OF MEA
8.6 SOUTH AMERICA
8.6.1 SOUTH AMERICA MARKET SNAPSHOT
8.6.2 BRAZIL
8.6.3 ARGENTINA
8.6.4 REST OF SOUTH AMERICA
9 GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 COMPANY MARKET RANKING
9.3 KEY DEVELOPMENT STRATEGIES
10 COMPANY PROFILES
10.1 CHARLES RIVER LABORATORIES
10.1.1 OVERVIEW
10.1.2 FINANCIAL PERFORMANCE
10.1.3 PRODUCT OUTLOOK
10.1.4 KEY DEVELOPMENTS
10.2 BOC SCIENCES
10.2.1 OVERVIEW
10.2.2 FINANCIAL PERFORMANCE
10.2.3 PRODUCT OUTLOOK
10.2.4 KEY DEVELOPMENTS
10.3 BIODURO-SUNDIA
10.3.1 OVERVIEW
10.3.2 FINANCIAL PERFORMANCE
10.3.3 PRODUCT OUTLOOK
10.3.4 KEY DEVELOPMENTS
10.4 SCHRÖDINGER, INCORPORATED
10.4.1 OVERVIEW
10.4.2 FINANCIAL PERFORMANCE
10.4.3 PRODUCT OUTLOOK
10.4.4 KEY DEVELOPMENTS
10.5 ARAGEN LIFE SCIENCES PVT. LIMITED.
10.5.1 OVERVIEW
10.5.2 FINANCIAL PERFORMANCE
10.5.3 PRODUCT OUTLOOK
10.5.4 KEY DEVELOPMENTS
10.6 ARIS PHARMACEUTICALS, INCORPORATED
10.6.1 OVERVIEW
10.6.2 FINANCIAL PERFORMANCE
10.6.3 PRODUCT OUTLOOK
10.6.4 KEY DEVELOPMENTS
10.7 BAYER AG
10.7.1 OVERVIEW
10.7.2 FINANCIAL PERFORMANCE
10.7.3 PRODUCT OUTLOOK
10.7.4 KEY DEVELOPMENTS
10.8 ASTRAZENECA PLC
10.8.1 OVERVIEW
10.8.2 FINANCIAL PERFORMANCE
10.8.3 PRODUCT OUTLOOK
10.8.4 KEY DEVELOPMENTS
10.9 ALBANY MOLECULAR RESEARCH INC. (AMRI)
10.9.1 OVERVIEW
10.9.2 FINANCIAL PERFORMANCE
10.9.3 PRODUCT OUTLOOK
10.9.4 KEY DEVELOPMENTS
01
お客様のニーズに合わせてレポートをカスタマイズ可能
02
ベテランの市場調査員による専門的な分析
03
安全で簡単に利用できるオンライン決済方法
04
お客様のご要望に応じて、特定の章を購入することができます。
05
すべてのレポートに専門的な日本語翻訳を提供
06
包括的でわかりやすいレポートを迅速にお届けします。
07
購入後も継続的なサポートとアップデートが受けられます。
We Accept
Copyright ©2022 All rights reserved